FDA Resolves Ovation Sabril Conflict Of Interest; Sets Jan. 7-8 Advisory Panel Meeting
This article was originally published in The Pink Sheet Daily
Executive Summary
Peripheral and CNS Drugs Advisory Committee to consider two indications for Sabril: to treat infantile spasms and as adjunctive therapy for refractory complex partial seizures in adults.